1 results match your criteria: "The Artificial Joint Engineering and Technology Research Center of Jiangxi ProvinceNanchang[Affiliation]"
The Beneficial Effects of Bisphosphonate-enoxacin on Cortical Bone Mass and Strength in Ovariectomized Rats.
Front Pharmacol
June 2017
Department of Orthopedics, The First Affiliated Hospital of Nanchang University, The Artificial Joint Engineering and Technology Research Center of Jiangxi ProvinceNanchang, China.
Article Synopsis
- Osteoporosis is a significant age-related condition that leads to low bone density and increased fracture risk, typically treated with bisphosphonates, though their long-term use can have serious side effects.
- A study introduced a new agent called bisphosphonate-enoxacin (BE) in ovariectomized rats and demonstrated that both BE and zoledronate improve cortical bone strength and properties, with BE showing even better results.
- BE may offer a safer and more effective alternative for treating osteoporosis by enhancing bone composition and strength compared to traditional bisphosphonates like zoledronate.